NEW YORK >> Packaged food makers and fast-food restaurants may ‌be forced to overhaul more of their products next year as ...

Using GLP-1s or considering it? New global research reveals social and psychological consequences for everyday lives.

The U.S. Food and Drug Administration has approved a weight-loss pill from Novo Nordisk ($NVO) that could speed up how appetite-suppressing drugs ...

GLP-1 medications, such as those with semaglutide, may help you lose weight that’s gained during perimenopause or menopause. They may have an enhanced effect when combined with menopausal hormone ...

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 global studies. Researchers found that although these medications, including ...

Patients taking blockbuster obesity drugs Ozempic or Wegovy will pack the pounds back on after they stop taking the medications. "I think this is what we see when people go on diets or different ...

The rapid adoption of GLP-1 weight loss medications — drugs like Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Zepbound and Mounjaro — is reshaping how Americans eat and shop. It's also changing ...

India's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster ...

The world of weight loss drugs can be confusing. There are so many types and brand names, and then there’s the big question: Does weight loss medication work? The short answer is yes. Weight loss ...

New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent ...